Enliven Therapeutics, Inc (ELVN) Misses Q1 EPS by 7c

Enliven Therapeutics, Inc (NASDAQ: ELVN) reported Q1 EPS of ($0.57), $0.07 worse than the analyst estimate of ($0.50).

For earnings history and earnings-related data on Enliven Therapeutics, Inc (ELVN) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• KeyCorp (KEY) files for 158.72M share offering by selling stockholders
• S&P Global (SPGI) Declares $0.97 Quarterly Dividend; 1% Yield